MedPath

National Eye Institute

National Eye Institute logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1968-01-01
Employees
101
Market Cap
-
Website
http://www.nei.nih.gov

Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS)

Completed
Conditions
Diabetic Retinopathy
First Posted Date
2002-12-10
Last Posted Date
2008-03-04
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
170
Registration Number
NCT00001612
Locations
🇺🇸

National Eye Institute (NEI), Bethesda, Maryland, United States

Diabetic Retinopathy and Visual Function Study

Completed
Conditions
Diabetic Retinopathy
Macular Degeneration
Vision, Subnormal
First Posted Date
2002-12-10
Last Posted Date
2008-03-04
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
100
Registration Number
NCT00001346
Locations
🇺🇸

National Eye Institute (NEI), Bethesda, Maryland, United States

The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis

Phase 1
Completed
Conditions
Arthritis, Juvenile Rheumatoid
Uveitis
First Posted Date
2002-12-10
Last Posted Date
2008-03-04
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
13
Registration Number
NCT00001614
Locations
🇺🇸

National Eye Institute (NEI), Bethesda, Maryland, United States

New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis

Phase 1
Completed
Conditions
Cystinosis
First Posted Date
2002-12-10
Last Posted Date
2008-03-04
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
51
Registration Number
NCT00001736
Locations
🇺🇸

National Eye Institute (NEI), Bethesda, Maryland, United States

Pigment Dispersion Syndrome With and Without Glaucoma

Completed
Conditions
Glaucoma
Glaucoma, Open-Angle
Ocular Hypertension
First Posted Date
2002-12-10
Last Posted Date
2008-03-04
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
175
Registration Number
NCT00001152
Locations
🇺🇸

National Eye Institute (NEI), Bethesda, Maryland, United States

Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration

Phase 1
Completed
Conditions
Choroidal Neovascularization
Macular Degeneration
First Posted Date
2002-12-10
Last Posted Date
2008-03-04
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
180
Registration Number
NCT00001615
Locations
🇺🇸

National Eye Institute (NEI), Bethesda, Maryland, United States

Vascular Endothelial Growth Factor (VEGF) in Uveitis

Completed
Conditions
Macular Edema, Cystoid
Uveitis
First Posted Date
2002-12-10
Last Posted Date
2008-03-04
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
60
Registration Number
NCT00001738
Locations
🇺🇸

National Eye Institute (NEI), Bethesda, Maryland, United States

Study of Eye Tissue for Sarcoidosis

Completed
Conditions
Sarcoidosis
First Posted Date
2002-12-10
Last Posted Date
2008-03-04
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
30
Registration Number
NCT00001278
Locations
🇺🇸

National Eye Institute (NEI), Bethesda, Maryland, United States

Modified Intraocular Lens to Reduce Eye Inflammation After Cataract Surgery in Uveitis Patients

Phase 2
Completed
Conditions
Cataracts
First Posted Date
2002-12-10
Last Posted Date
2008-03-04
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
80
Registration Number
NCT00001311
Locations
🇺🇸

National Eye Institute (NEI), Bethesda, Maryland, United States

Visual Function and Ocular Pigmentation in Albinism

Completed
Conditions
Albinism
Albinism, Ocular
Albinism, Oculocutaneous
First Posted Date
2002-12-10
Last Posted Date
2008-03-04
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
130
Registration Number
NCT00001153
Locations
🇺🇸

National Eye Institute (NEI), Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath